ICHCC/LinkedIn
May 2, 2026, 10:24
From Gene Mutation to Clot Risk in Factor V Leiden – ICHCC
Iranian Comprehensive Hemophilia Care Center shared a post on LinkedIn:
- is the most common inherited blood clotting disorder in populations of European descent, caused by a mutation in the \(F5\) gene. It makes blood more prone to clotting (thrombophilia) because the mutated Factor V protein resists inactivation by protein C.
- While most carriers never experience a clot, it significantly increases the risk of deep vein thrombosis (DVT) and pulmonary embolism.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 08:51Zia Ullah Shah: Advancing Early Diagnosis of Wilson Disease With AI and Biomarkers
-
Sep 19, 2026, 03:15Paulus Kirchhof: Europe’s Safe Hearts Plan to Reduce Cardiovascular Mortality
-
Sep 19, 2026, 03:10James Smith: Brain Training and Exercise for Cognitive Recovery After Stroke
-
Sep 19, 2026, 03:03Lesley Van Wyk: ASH Releases New Iron Deficiency Diagnosis Guidelines
-
Sep 19, 2026, 02:53Francisco Chacón-Lozsán: Acute Ischemic Stroke in 2026 – Expanding the Treatment Window
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal